New Managed Care Study Results from Jacquelyn Roth et al Described (Insurance Type Does Not Impact Adverse Outcomes Following Breast Reduction Surgery): Managed Care

2025 DEC 26 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Investigators discuss new findings in Managed Care. According to news reporting originating in New York City, New York, by NewsRx journalists, research stated, “Previous literature suggests that treatment delays and poorer baseline health among patients with Medicare and Medicaid, compared to those with private insurance, contribute to worse outcomes across a range of procedures. However, the impact of insurance type on breast reduction surgery remains underexplored.”

The news reporters obtained a quote from the research, “This study evaluates disparities in breast reduction outcomes among patients with private insurance, Medicaid, and Medicare. A retrospective chart review was conducted of patients who had undergone breast reduction surgery between 2019 and 2023. Patient demographics were collected, and medical insurance was categorized as private, Medicare, or Medicaid. Outcomes studied included complications and procedure length. Regression analyses assessed the association between insurance types and postoperative outcomes. Statistical significance was set at P< 0.05. Of the 1085 patients included, 627 had private insurance (57.8%), 363 had Medicaid insurance (33.5%), and 95 had Medicare insurance (8.8%). Age, race, ethnicity, and resected tissue weight differed significantly among the groups. Univariate analysis showed that patients with Medicare insurance had higher odds of postoperative infection (OR, 3.48; P = 0.009), and patients with Medicaid insurance had lower odds of complications requiring reoperation (OR, 0.35; P = 0.04). However, neither association remained significant in multivariate analysis. In contrast, operative time was significantly shorter for patients with Medicaid insurance compared to those with private insurance in both univariate (Beta = -10.14; P = 0.003) and multivariate models (Beta = -11.30; P = 0.006).”

According to the news reporters, the research concluded: “While insurance type was not independently associated with postoperative complications following breast reduction surgery, patients with Medicaid insurance experienced significantly shorter operative times, suggesting that insurance type may influence some aspects of intraoperative care, whereas broader social determinants of health likely have a greater impact on postoperative outcomes.”

This research has been peer-reviewed.

For more information on this research see: Insurance Type Does Not Impact Adverse Outcomes Following Breast Reduction Surgery. Annals of Plastic Surgery, 2026;96(1):19-24. Annals of Plastic Surgery can be contacted at: Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA. (Lippincott Williams and Wilkins - www.lww.com; Annals of Plastic Surgery - http://journals.lww.com/annalsplasticsurgery/pages/default.aspx)

Our news correspondents report that additional information may be obtained by contacting Jacquelyn Roth, the Icahn School of Medicine at Mount Sinai Hospital, New York, NY. Additional authors for this research include Keisha E. Montalmant, Brooke Barrow, Jamie Frost, Bernice Yu, Max Godek, Ethan Fung and Peter W. Henderson.

The publisher of the journal Annals of Plastic Surgery can be contacted at: Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)